ChoA Pharmaceutical Co.Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: -0.016x

ChoA Pharmaceutical Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, ChoA Pharmaceutical Co.Ltd (034940) has a cash flow conversion efficiency ratio of -0.016x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-505.40 Million ≈ $-342.50K USD) by net assets (₩32.06 Billion ≈ $21.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of ChoA Pharmaceutical Co.Ltd (2004–2025)

Cash flow conversion efficiency of ChoA Pharmaceutical Co.Ltd from 2004 to 2025. This chart illustrates how ChoA Pharmaceutical Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ChoA Pharmaceutical Co.Ltd stock price for real-time trading data and today's change.

ChoA Pharmaceutical Co.Ltd Cash Flow Conversion Ratio Explained

ChoA Pharmaceutical Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

ChoA Pharmaceutical Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ChoA Pharmaceutical Co.Ltd ranked by their cash flow conversion efficiency. Also see ChoA Pharmaceutical Co.Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Canasil Resources Inc. V:CLZ-H	0.175x
ICDS Limited NSE:ICDSLTD	0.021x
Cerenome, Inc. NASDAQ:CNSY	-1.306x
NEVADA LITHIUM RESOURCES F:87K	-0.009x
Redcastle Resources Ltd AU:RC1	-0.103x
E79 Gold Mines Ltd AU:E79	-0.156x
XOX Bhd KLSE:0165	0.194x
Prasidha Aneka Niaga Tbk JK:PSDN	-0.096x

Annual Cash Flow Conversion Efficiency for ChoA Pharmaceutical Co.Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of ChoA Pharmaceutical Co.Ltd from 2004 to 2025. Review 034940 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩21.77 Billion ≈ $14.75 Million	₩-4.18 Billion ≈ $-2.83 Million	-0.192x	-34.84%
2024-12-31	₩31.38 Billion ≈ $21.26 Million	₩-4.47 Billion ≈ $-3.03 Million	-0.142x	-274.13%
2023-12-31	₩38.76 Billion ≈ $26.27 Million	₩-1.48 Billion ≈ $-999.75K	-0.038x	-39.39%
2022-12-31	₩52.84 Billion ≈ $35.81 Million	₩-1.44 Billion ≈ $-977.89K	-0.027x	+7.92%
2021-12-31	₩49.92 Billion ≈ $33.83 Million	₩-1.48 Billion ≈ $-1.00 Million	-0.030x	-189.97%
2020-12-31	₩58.30 Billion ≈ $39.51 Million	₩1.92 Billion ≈ $1.30 Million	0.033x	-57.93%
2019-12-31	₩53.06 Billion ≈ $35.96 Million	₩4.16 Billion ≈ $2.82 Million	0.078x	+106.82%
2018-12-31	₩53.96 Billion ≈ $36.57 Million	₩2.04 Billion ≈ $1.39 Million	0.038x	+403.82%
2017-12-31	₩54.18 Billion ≈ $36.71 Million	₩-675.51 Million ≈ $-457.78K	-0.012x	-164.11%
2016-12-31	₩47.84 Billion ≈ $32.42 Million	₩930.42 Million ≈ $630.53K	0.019x	-22.74%
2015-12-31	₩47.15 Billion ≈ $31.96 Million	₩1.19 Billion ≈ $804.48K	0.025x	+85.49%
2014-12-31	₩46.09 Billion ≈ $31.23 Million	₩625.52 Million ≈ $423.90K	0.014x	-80.55%
2013-12-31	₩50.63 Billion ≈ $34.31 Million	₩3.53 Billion ≈ $2.39 Million	0.070x	-68.88%
2004-12-31	₩15.94 Billion ≈ $10.81 Million	₩3.57 Billion ≈ $2.42 Million	0.224x	--

About ChoA Pharmaceutical Co.Ltd

KQ:034940 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$6.76 Million

₩9.98 Billion KRW

Market Cap Rank

#27861 Global

#2053 in Korea

Share Price

₩1610.00

Change (1 day)

+1.90%

52-Week Range

₩505.00 - ₩13350.00

All Time High

₩13350.00